Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts
Open accessAbstract
Viral replication usually requires that innate intracellular lines of defence be overcome, a task usually accomplished by specialized viral gene products. The virion infectivity factor (Vif) protein of human immunodeficiency virus (HIV) is required during the late stages of viral production to counter the antiviral activity of APOBEC3G (apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like 3G; also known as CEM15), a protein expressed notably in human T lymphocytes. When produced in the presence of APOBEC3G, vif-defective virus is non-infectious. APOBEC3G is closely related to APOBEC1, the central component of an RNA-editing complex that deaminates a cytosine residue in apoB messenger RNA. APOBEC family members also have potent DNA mutator activity through dC deamination; however, whether the editing potential of APOBEC3G has any relevance to HIV inhibition is unknown. Here, we demonstrate that it does, as APOBEC3G exerts its antiviral effect during reverse transcription to trigger G-to-A hypermutation in the nascent retroviral DNA. We also find that APOBEC3G can act on a broad range of retroviruses in addition to HIV, suggesting that hypermutation by editing is a general innate defence mechanism against this important group of pathogens.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Cellular RNA polymerase II, along with various viral and host factors, also influences retroviral mutations, particularly in HIV-1.
“However, cellular RNA polymerase II, along with various viral and host factors, also influences retroviral mutations, particularly in HIV-1 (O’Neil et al. 2002, Mangeat et al. 2003, Chiu and Greene 2006, Hughes 2015).”
From Beyond reverse transcription: molecular mechanisms and emerging paradigms in retroviral replication (2026) · cites this paper as Mangeat et al. 2003
Cites
Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein
Sheehy, A. M., Gaddis, N., Choi, J. D., & Malim, M. H. (2002) · Nature · doi:10.1038/nature00939 · Cited by 2,330 · see citing works
Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo
Zufferey, R., Nagy, D., Mandel, R. J., Naldini, L., & Trono, D. (1997) · Nature Biotechnology · doi:10.1038/nbt0997-871 · Cited by 1,977 · see citing works
Self-citationA novel form of tissue-specific RNA processing produces apolipoprotein-B48 in intestine
Powell, L. M., Wallis, S. C., Pease, R. J., Edwards, Y. H., Knott, T. J., & Scott, J. (1987) · Cell · doi:10.1016/0092-8674(87)90510-1 · Cited by 1,039 · see citing works
Transcription-targeted DNA deamination by the AID antibody diversification enzyme
Chaudhuri, J., Tian, M., Khuong, C., Chua, K. F., Pinaud, E., & Alt, F. W. (2003) · Nature · doi:10.1038/nature01574 · Cited by 746 · see citing works
An Anthropoid-Specific Locus of Orphan C to U RNA-Editing Enzymes on Chromosome 22
Jarmuz, A., Chester, A., Bayliss, J., Gisbourne, J., Dunham, I., Scott, J., & Navaratnam, N. (2002) · Genomics · doi:10.1006/geno.2002.6718 · Cited by 711 · see citing works
A quantitative assay for HIV DNA integration in vivo
Butler, S. L., Hansen, M. S., & Bushman, F. D. (2001) · Nature Medicine · doi:10.1038/87979 · Cited by 688 · see citing works
Molecular Cloning of an Apolipoprotein B Messenger RNA Editing Protein
Teng, B.-B., Burant, C., & Davidson, N. O. (1993) · Science · doi:10.1126/science.8511591 · Cited by 626 · see citing works
RNA Editing Enzyme APOBEC1 and Some of Its Homologs Can Act as DNA Mutators
Harris, R. S., Petersen‐Mahrt, S. K., & Neuberger, M. S. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00742-6 · Cited by 604 · see citing works
Role of vif in replication of human immunodeficiency virus type 1 in CD4+ T lymphocytes
Gabuzda, D. H., Lawrence, K., Langhoff, E., Terwilliger, E., Dorfman, T., Haseltine, W. A., & Sodroski, J. (1992) · Journal of Virology · doi:10.1128/jvi.66.11.6489-6495.1992 · Cited by 444 · see citing works
Vif is crucial for human immunodeficiency virus type 1 proviral DNA synthesis in infected cells
von Schwedler, U. K., Song, J., Aiken, C., & Trono, D. (1993) · Journal of Virology · doi:10.1128/jvi.67.8.4945-4955.1993 · Cited by 441 · see citing works
Self-citationHIV-1 Reverse Transcription A Termination Step at the Center of the Genome
Charneau, P., Mirambeau, G., Roux, P., Paulous, S., BUC, H. C., & Clavel, F. (1994) · Journal of Molecular Biology · doi:10.1006/jmbi.1994.1542 · Cited by 388 · see citing works
Transmission of antiretroviral-drug-resistant HIV-1 variants
Yerly, S., Kaiser, L., Race, E., Bru, J.-P., Clavel, F., & Perrin, L. (1999) · The Lancet · doi:10.1016/s0140-6736(98)12262-6 · Cited by 383 · see citing works
Self-citationSelection, recombination, and G----A hypermutation of human immunodeficiency virus type 1 genomes
Vartanian, J., Meyerhans, A., Åsjö, B., & Wain–Hobson, S. (1991) · Journal of Virology · doi:10.1128/jvi.65.4.1779-1788.1991 · Cited by 340 · see citing works
Pathak, V. K., & Temin, H. M. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.16.6019 · Cited by 279 · see citing works
Stable gene transfer to the nervous system using a non-primate lentiviral vector
Mitrophanous, K. A., Yoon, S., Rohll, J. B., Patil, D., Wilkes, F. J., Kim, V. N., Kingsman, S. M., Kingsman, A. J., & Mazarakis, N. D. (1999) · Gene Therapy · doi:10.1038/sj.gt.3301023 · Cited by 277 · see citing works
Highly Purified Human Immunodeficiency Virus Type 1 Reveals a Virtual Absence of Vif in Virions
Dettenhofer, M., & Yu, X.-F. (1999) · Journal of Virology · doi:10.1128/jvi.73.2.1460-1467.1999 · Cited by 239 · see citing works
Kotsopoulou, E., Kim, V. N., Kingsman, A. J., Kingsman, S. M., & Mitrophanous, K. A. (2000) · Journal of Virology · doi:10.1128/jvi.74.10.4839-4852.2000 · Cited by 228 · see citing works
Cytoplasmic Recruitment of INI1 and PML on Incoming HIV Preintegration Complexes
Turelli, P., Doucas, V., Craig, E., Mangeat, B., Klages, N., Evans, R. M., Kalpana, G. V., & Trono, D. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00255-6 · Cited by 223 · see citing works
Self-citationNégre, D., Mangeot, P.-E., Duisit, G., Blanchard, S., Vidalain, P., Leissner, P., Winter, A.-J., Rabourdin‐Combe, C., Mehtali, M., Moullier, P., et al. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301292 · Cited by 206 · see citing works
Simon, J. H., & Malim, M. H. (1996) · Journal of Virology · doi:10.1128/jvi.70.8.5297-5305.1996 · Cited by 188 · see citing works
MacGinnitie, A. J., Anant, S., & Davidson, N. O. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.24.14768 · Cited by 130 · see citing works
Johnson, P. R., Hamm, T. E., Goldstein, S. C., Kitov, S., & Hirsch, V. M. (1991) · Virology · doi:10.1016/0042-6822(91)90769-8 · Cited by 117 · see citing works
Günther, S., Sommer, G., Plikat, U., Iwanska, A., Wain–Hobson, S., Will, H., & Meyerhans, A. (1997) · Virology · doi:10.1006/viro.1997.8676 · Cited by 86 · see citing works
In Vivo Analysis of Human T-Cell Leukemia Virus Type 1 Reverse Transcription Accuracy
Mansky, L. M. (2000) · Journal of Virology · doi:10.1128/jvi.74.20.9525-9531.2000 · Cited by 85 · see citing works
Klarmann, G. J., Chen, X., North, T. W., & Preston, B. D. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207223200 · Cited by 77 · see citing works
Turelli, P., Guiguen, F., Mornex, J., Vigne, R., & Quérat, G. (1997) · Journal of Virology · doi:10.1128/jvi.71.6.4522-4530.1997 · Cited by 77 · see citing works
Self-citationErratic G → A Hypermutation within a Complete Caprine Arthritis-Encephalitis Virus (CAEV) Provirus
Wain–Hobson, S., Sonigo, P., Guyader, M., Gazit, A., & Henry, M. (1995) · Virology · doi:10.1006/viro.1995.1261 · Cited by 52 · see citing works
Borman, A. M., Quillent, C., Charneau, P., Kean, K. M., & Clavel, F. (1995) · Virology · doi:10.1006/viro.1995.1191 · Cited by 51 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Rates of evolutionary change in viruses: patterns and determinants
Duffy, S., Shackelton, L. A., & Holmes, E. C. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2323 · Cited by 1,548 · see citing works
Induction of APOBEC3G Ubiquitination and Degradation by an HIV-1 Vif-Cul5-SCF Complex
Yu, X., Yu, Y., Liu, B., Luo, K., Kong, W., Mao, P., & Yu, X.-F. (2003) · Science · doi:10.1126/science.1089591 · Cited by 1,194 · see citing works
Type I Interferons in Host Defense
Stetson, D. B., & Medzhitov, R. M. (2006) · Immunity · doi:10.1016/j.immuni.2006.08.007 · Cited by 1,194 · see citing works
The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif
Sheehy, A. M., Gaddis, N., & Malim, M. H. (2003) · Nature Medicine · doi:10.1038/nm945 · Cited by 961 · see citing works
Sanjuán, R., & Domingo‐Calap, P. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2299-6 · Cited by 952 · see citing works
Quasispecies Theory and the Behavior of RNA Viruses
Lauring, A. S., & Andino, R. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1001005 · Cited by 840 · see citing works
HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation
Marin, M., Rose, K. M., Kozak, S. L., & Kabat, D. (2003) · Nature Medicine · doi:10.1038/nm946 · Cited by 794 · see citing works
Stopak, K., de Noronha, C. M. C., Yonemoto, W. M., & Greene, W. C. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00353-8 · Cited by 723 · see citing works
Retroviral restriction by APOBEC proteins
Harris, R. S., & Liddament, M. T. (2004) · Nature reviews. Immunology · doi:10.1038/nri1489 · Cited by 657 · see citing works
Cytidine Deamination of Retroviral DNA by Diverse APOBEC Proteins
Bishop, K. N., Holmes, R. K., Sheehy, A. M., Davidson, N. O., Cho, S., & Malim, M. H. (2004) · Current Biology · doi:10.1016/j.cub.2004.06.057 · Cited by 613 · see citing works
Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome
Yu, Q., König, R., Pillai, S. K., Chiles, K., Kearney, M. F., Palmer, S., Richman, D., Coffin, J. M., & Landau, N. R. (2004) · Nature Structural & Molecular Biology · doi:10.1038/nsmb758 · Cited by 596 · see citing works
The AID/APOBEC family of nucleic acid mutators
Conticello, S. G. (2008) · Genome biology · doi:10.1186/gb-2008-9-6-229 · Cited by 544 · see citing works
Yan, N., & Chen, Z. J. (2012) · Nature Immunology · doi:10.1038/ni.2229 · Cited by 535 · see citing works
Harris, R. S., & Dudley, J. P. (2015) · Virology · doi:10.1016/j.virol.2015.03.012 · Cited by 518 · see citing works
HIV-1 Reverse TranscriptionPreprint
Hu, W.-S., & Hughes, S. H. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006882 · Cited by 515 · see citing works
Evolution of the AID/APOBEC Family of Polynucleotide (Deoxy)cytidine Deaminases
Conticello, S. G., Thomas, C. J. F., Petersen‐Mahrt, S. K., & Neuberger, M. S. (2004) · Molecular Biology and Evolution · doi:10.1093/molbev/msi026 · Cited by 489 · see citing works
Ancient adaptive evolution of the primate antiviral DNA-editing enzyme APOBEC3G
Sawyer, S. L., Emerman, M., & Malik, H. S. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020275 · Cited by 485 · see citing works
Antiviral Function of APOBEC3G Can Be Dissociated from Cytidine Deaminase Activity
Newman, E. N. C., Holmes, R. K., Craig, H. M., Klein, K. C., Lingappa, J. R., Malim, M. H., & Sheehy, A. M. (2005) · Current Biology · doi:10.1016/j.cub.2004.12.068 · Cited by 480 · see citing works
HIV Restriction Factors and Mechanisms of EvasionPreprint
Malim, M. H., & Bieniasz, P. D. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006940 · Cited by 474 · see citing works
Mehle, A., Strack, B., Ancuța, P., Zhang, C., McPike, M. P., & Gabuzda, D. H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313093200 · Cited by 470 · see citing works
The Vif Protein of HIV Triggers Degradation of the Human Antiretroviral DNA Deaminase APOBEC3G
Conticello, S. G., Harris, R. S., & Neuberger, M. S. (2003) · Current Biology · doi:10.1016/j.cub.2003.10.034 · Cited by 468 · see citing works
A second human antiretroviral factor, APOBEC3F, is suppressed by the HIV‐1 and HIV‐2 Vif proteins
Wiegand, H. L., Doehle, B., Bogerd, H. P., & Cullen, B. R. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600246 · Cited by 466 · see citing works
Intrinsic immunity: a front-line defense against viral attack
Bieniasz, P. D. (2004) · Nature Immunology · doi:10.1038/ni1125 · Cited by 450 · see citing works
Cellular APOBEC3G restricts HIV-1 infection in resting CD4+ T cells
Chiu, Y., Soros, V. B., Kreisberg, J. F., Stopak, K., Yonemoto, W. M., & Greene, W. C. (2005) · Nature · doi:10.1038/nature03493 · Cited by 437 · see citing works
RetractedAPOBEC3F Properties and Hypermutation Preferences Indicate Activity against HIV-1 In Vivo
Liddament, M. T., Brown, W. L., Schumacher, A. J., & Harris, R. S. (2004) · Current Biology · doi:10.1016/j.cub.2004.06.050 · Cited by 437 · see citing works
Inhibition of Hepatitis B Virus Replication by APOBEC3G
Turelli, P., Mangeat, B., Jost, S., Vianin, S., & Trono, D. (2004) · Science · doi:10.1126/science.1092066 · Cited by 432 · see citing works
Self-citationHuman APOBEC3F Is Another Host Factor That Blocks Human Immunodeficiency Virus Type 1 Replication
Zheng, Y., Irwin, D., Kurosu, T., Tokunaga, K., Sata, T., & Peterlin, B. M. (2004) · Journal of Virology · doi:10.1128/jvi.78.11.6073-6076.2004 · Cited by 430 · see citing works
The structural biology of HIV-1: mechanistic and therapeutic insights
Engelman, A., & Cherepanov, P. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2747 · Cited by 426 · see citing works
Chiu, Y., & Greene, W. C. (2008) · Annual Review of Immunology · doi:10.1146/annurev.immunol.26.021607.090350 · Cited by 417 · see citing works
APOBEC3A Is a Potent Inhibitor of Adeno-Associated Virus and Retrotransposons
Chen, H., Lilley, C. E., Yu, Q., Lee, D. V., Chou, J., Narvaiza, I., Landau, N. R., & Weitzman, M. D. (2006) · Current Biology · doi:10.1016/j.cub.2006.01.031 · Cited by 385 · see citing works
Cellular inhibitors of long interspersed element 1 and Alu retrotransposition
Bogerd, H. P., Wiegand, H. L., Hulme, A. E., Garcia-Perez, J. L., O’Shea, K., Moran, J. V., & Cullen, B. R. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603313103 · Cited by 372 · see citing works
Retrovirus resistance factors Ref1 and Lv1 are species-specific variants of TRIM5α
Hatziioannou, T., Pérez-Caballero, D., Yang, A., Cowan, S., & Bieniasz, P. D. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402361101 · Cited by 371 · see citing works
Refsland, E. W., Stenglein, M. D., Shindo, K., Albin, J. S., Brown, W. L., & Harris, R. S. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq174 · Cited by 356 · see citing works
The role of mutational robustness in RNA virus evolution
Lauring, A. S., Frydman, J., & Andino, R. (2013) · Nature Reviews Microbiology · doi:10.1038/nrmicro3003 · Cited by 354 · see citing works
APOBEC3 Proteins Inhibit Human LINE-1 Retrotransposition
Muckenfuß, H., Hamdorf, M., Held, U., Perković, M., Löwer, J., Cichutek, K., Flory, E., Schumann, G. G., & Münk, C. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601716200 · Cited by 353 · see citing works
Keckesova, Z., Ylinen, L. M. J., & Towers, G. J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402474101 · Cited by 342 · see citing works
APOBEC3G cytidine deaminase inhibits retrotransposition of endogenous retroviruses
Esnault, C., Heidmann, O., Delebecque, F., Dewannieux, M., Ribet, D., Hance, A. J., Heidmann, T., & Schwartz, O. (2005) · Nature · doi:10.1038/nature03238 · Cited by 341 · see citing works
HIV-1 Vif, APOBEC, and Intrinsic Immunity
Goila-Gaur, R., & Strebel, K. (2008) · Retrovirology · doi:10.1186/1742-4690-5-51 · Cited by 341 · see citing works
Henderson, S. R., Chakravarthy, A., Su, X., Boshoff, C., & Fenton, T. R. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.05.012 · Cited by 340 · see citing works
Animal models for HIV/AIDS research
Hatziioannou, T., & Evans, D. T. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2911 · Cited by 338 · see citing works
Beale, R. C. L., Petersen‐Mahrt, S. K., Watt, I. N., Harris, R. S., Rada, C. A., & Neuberger, M. S. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.01.046 · Cited by 337 · see citing works
Defining APOBEC3 Expression Patterns in Human Tissues and Hematopoietic Cell Subsets
Koning, F. A., Newman, E. N. C., Kim, E., Kunstman, K., Wolinsky, S. M., & Malim, M. H. (2009) · Journal of Virology · doi:10.1128/jvi.01089-09 · Cited by 334 · see citing works
Evidence for Editing of Human Papillomavirus DNA by APOBEC3 in Benign and Precancerous Lesions
Vartanian, J., Guétard, D., Henry, M., & Wain–Hobson, S. (2008) · Science · doi:10.1126/science.1153201 · Cited by 327 · see citing works
APOBEC3G Inhibits Elongation of HIV-1 Reverse Transcripts
Bishop, K. N., Verma, M., Kim, E., Wolinsky, S. M., & Malim, M. H. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000231 · Cited by 326 · see citing works
APOBEC3 proteins mediate the clearance of foreign DNA from human cells
Stenglein, M. D., Burns, M. B., Li, M., Lengyel, J., & Harris, R. S. (2010) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1744 · Cited by 326 · see citing works
Cellular Proteins in Influenza Virus Particles
Shaw, M. L., Stone, K. L., Colangelo, C. M., Gulcicek, E. E., & Palese, P. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000085 · Cited by 324 · see citing works
Deaminase-independent inhibition of HIV-1 reverse transcription by APOBEC3G
Iwatani, Y., Chan, D., Wang, F., Stewart-Maynard, K. M., Sugiura, W., Gronenborn, A. M., Rouzina, I. F., Williams, M. C., Musier‐Forsyth, K., & Levin, J. G. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm750 · Cited by 321 · see citing works
DNA precursor metabolism and genomic stability
Mathews, C. K. (2006) · The FASEB Journal · doi:10.1096/fj.06-5730rev · Cited by 311 · see citing works
Reconstitution of an Infectious Human Endogenous Retrovirus
Lee, Y. N., & Bieniasz, P. D. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030010 · Cited by 311 · see citing works
No evidence for increased transmissibility from recurrent mutations in SARS-CoV-2
van Dorp, L., Richard, D., Tan, C. C. S., Shaw, L. P., Acman, M., & Balloux, F. (2020) · Nature Communications · doi:10.1038/s41467-020-19818-2 · Cited by 310 · see citing works
Schröfelbauer, B., Chen, D., & Landau, N. R. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307132101 · Cited by 309 · see citing works
Kao, S., Khan, M. A., Miyagi, E., Plishka, R. J., Buckler-White, A. J., & Strebel, K. (2003) · Journal of Virology · doi:10.1128/jvi.77.21.11398-11407.2003 · Cited by 309 · see citing works
Complementary function of the two catalytic domains of APOBEC3G
Navarro, F., Bollman, B., Chen, H., König, R., Yu, Q., Chiles, K., & Landau, N. R. (2005) · Virology · doi:10.1016/j.virol.2005.01.011 · Cited by 308 · see citing works
Holmes, R. K., Koning, F. A., Bishop, K. N., & Malim, M. H. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m607298200 · Cited by 306 · see citing works
Suspène, R., Guétard, D., Henry, M., Sommer, P., Wain–Hobson, S., & Vartanian, J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408223102 · Cited by 305 · see citing works
APOBEC3G DNA deaminase acts processively 3′ → 5′ on single-stranded DNA
Chelico, L., Pham, P., Calabrese, P. P., & Goodman, M. F. (2006) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1086 · Cited by 305 · see citing works
Yu, Y., Xiao, Z., Ehrlich, E. S., Yu, X., & Yu, X.-F. (2004) · Genes & Development · doi:10.1101/gad.1250204 · Cited by 302 · see citing works
Bogerd, H. P., Doehle, B., Wiegand, H. L., & Cullen, B. R. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307713101 · Cited by 295 · see citing works
Mehle, A., Gonçalves, J., Santa‐Marta, M., McPike, M. P., & Gabuzda, D. H. (2004) · Genes & Development · doi:10.1101/gad.1249904 · Cited by 294 · see citing works
Antiviral Potency of APOBEC Proteins Does Not Correlate with Cytidine Deamination
Bishop, K. N., Holmes, R. K., & Malim, M. H. (2006) · Journal of Virology · doi:10.1128/jvi.00839-06 · Cited by 292 · see citing works
APOBEC3B and APOBEC3C Are Potent Inhibitors of Simian Immunodeficiency Virus Replication
Yu, Q., Chen, D., König, R., Mariani, R., Unutmaz, D., & Landau, N. R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408802200 · Cited by 290 · see citing works
Peng, G., Lei, K. J., Jin, W., Greenwell‐Wild, T., & Wahl, S. M. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20051512 · Cited by 290 · see citing works
HPV16 E7 Genetic Conservation Is Critical to Carcinogenesis
Mirabello, L. J., Yeager, M., Yu, K. F., Clifford, G. M., Xiao, Y., Zhu, B., Cullen, M., Boland, J. F., Wentzensen, N., Nelson, C. W., et al. (2017) · Cell · doi:10.1016/j.cell.2017.08.001 · Cited by 285 · see citing works
Blankson, J. N., Bailey, J. R., Thayil, S. M., Yang, H., Lassen, K. G., Lai, J., Gandhi, S. K., Siliciano, J. D., Williams, T. M., & Siliciano, R. F. (2006) · Journal of Virology · doi:10.1128/jvi.02165-06 · Cited by 282 · see citing works
Understanding HIV-1 latency provides clues for the eradication of long-term reservoirs
Coiras, M., López‐Huertas, M. R., Pérez‐Olmeda, M., & Alcamı́, J. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2223 · Cited by 281 · see citing works
Ubiquitination, Ubiquitin-like Modifiers, and Deubiquitination in Viral Infection
Isaacson, M. K., & Ploegh, H. L. (2009) · Cell Host & Microbe · doi:10.1016/j.chom.2009.05.012 · Cited by 281 · see citing works
Bailey, J. R., Williams, T. M., Siliciano, R. F., & Blankson, J. N. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20052319 · Cited by 281 · see citing works
The Restriction Factors of Human Immunodeficiency Virus
Harris, R. S., Hultquist, J. F., & Evans, D. T. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.r112.416925 · Cited by 281 · see citing works
Role and Mechanism of Action of the APOBEC3 Family of Antiretroviral Resistance Factors
Cullen, B. R. (2006) · Journal of Virology · doi:10.1128/jvi.80.3.1067-1076.2006 · Cited by 280 · see citing works
APOBEC-mediated viral restriction: not simply editing?
Holmes, R. K., Malim, M. H., & Bishop, K. N. (2007) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2007.01.004 · Cited by 278 · see citing works
APOBEC3G Incorporation into Human Immunodeficiency Virus Type 1 Particles
Zennou, V., Pérez-Caballero, D., Göttlinger, H. G., & Bieniasz, P. D. (2004) · Journal of Virology · doi:10.1128/jvi.78.21.12058-12061.2004 · Cited by 278 · see citing works
Macrophages and their relevance in Human Immunodeficiency Virus Type I infection
Koppensteiner, H., Brack‐Werner, R., & Schindler, M. (2012) · Retrovirology · doi:10.1186/1742-4690-9-82 · Cited by 278 · see citing works
Mammalian transposable elements and their impacts on genome evolution
Platt, R. N., Vandewege, M. W., & Ray, D. A. (2018) · Chromosome Research · doi:10.1007/s10577-017-9570-z · Cited by 278 · see citing works
APOBEC3B and APOBEC3F Inhibit L1 Retrotransposition by a DNA Deamination-independent Mechanism
Stenglein, M. D., & Harris, R. S. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602367200 · Cited by 277 · see citing works
APOBEC proteins and intrinsic resistance to HIV-1 infection
Malim, M. H. (2008) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2008.0185 · Cited by 276 · see citing works
Gallois‐Montbrun, S., Kramer, B., Swanson, C. M., Byers, H. L., Lynham, S., Ward, M. A., & Malim, M. H. (2006) · Journal of Virology · doi:10.1128/jvi.02287-06 · Cited by 276 · see citing works
Mbisa, J. L., Barr, R., Thomas, J. A., Vandegraaff, N., Dorweiler, I. J., Svarovskaia, E. S., Brown, W. L., Mansky, L. M., Gorelick, R. J., Harris, R. S., et al. (2007) · Journal of Virology · doi:10.1128/jvi.00272-07 · Cited by 273 · see citing works
Peter Simmonds, K. (2020) · mSphere · doi:10.1128/msphere.00408-20 · Cited by 271 · see citing works
Barreto, V. M., Reina‐San‐Martin, B., Ramiro, A. R., McBride, K. M., & Nussenzweig, M. C. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00309-5 · Cited by 270 · see citing works
APOBEC3A and APOBEC3B are potent inhibitors of LTR-retrotransposon function in human cells
Bogerd, H. P. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkj416 · Cited by 270 · see citing works
Svarovskaia, E. S., Xu, H., Mbisa, J. L., Barr, R., Gorelick, R. J., Ono, A., Freed, E. O., Hu, W.-S., & Pathak, V. K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405761200 · Cited by 267 · see citing works
Nature, Position, and Frequency of Mutations Made in a Single Cycle of HIV-1 Replication
Abram, M. E., Ferris, A. L., Shao, W., Alvord, W. G., & Hughes, S. H. (2010) · Journal of Virology · doi:10.1128/jvi.00915-10 · Cited by 264 · see citing works
Intrinsic host restrictions to HIV-1 and mechanisms of viral escape
Simon, V. R., Bloch, N., & Landau, N. R. (2015) · Nature Immunology · doi:10.1038/ni.3156 · Cited by 260 · see citing works
Going Wild: Lessons from Naturally Occurring T-Lymphotropic Lentiviruses
VandeWoude, S., & Apetrei, C. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.00009-06 · Cited by 260 · see citing works
The Developmental Control of Transposable Elements and the Evolution of Higher Species
Friedli, M., & Trono, D. (2015) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-100814-125514 · Cited by 258 · see citing works
Self-citationThe Evolution of Endogenous Viral Elements
Holmes, E. C. (2011) · Cell Host & Microbe · doi:10.1016/j.chom.2011.09.002 · Cited by 255 · see citing works
Identification of APOBEC3DE as Another Antiretroviral Factor from the Human APOBEC Family
Dang, Y., Wang, X., Esselman, W. J., & Zheng, Y. (2006) · Journal of Virology · doi:10.1128/jvi.01123-06 · Cited by 255 · see citing works
Functions and consequences of AID/APOBEC-mediated DNA and RNA deamination
Pecori, R., Giorgio, S. D., Lorenzo, J. P., & Papavasiliou, F. N. (2022) · Nature Reviews Genetics · doi:10.1038/s41576-022-00459-8 · Cited by 254 · see citing works
Bonvin, M., Achermann, F., Greeve, I., Stroka, D., Keogh, A., Inderbitzin, D., Candinas, D., Sommer, P., Wain–Hobson, S., Vartanian, J., et al. (2006) · Hepatology · doi:10.1002/hep.21187 · Cited by 252 · see citing works
High-molecular-mass APOBEC3G complexes restrict Alu retrotransposition
Chiu, Y., Witkowska, H. E., Hall, S. C., Santiago, M. L., Soros, V. B., Esnault, C., Heidmann, T., & Greene, W. C. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604524103 · Cited by 244 · see citing works
Human Tripartite Motif 5α Domains Responsible for Retrovirus Restriction Activity and Specificity
Pérez-Caballero, D., Hatziioannou, T., Yang, A., Cowan, S., & Bieniasz, P. D. (2005) · Journal of Virology · doi:10.1128/jvi.79.14.8969-8978.2005 · Cited by 244 · see citing works
The Interaction between HIV-1 Gag and APOBEC3G
Cen, S., Guo, F., Niu, M., Saadatmand, J., Deflassieux, J., & Kleiman, L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402062200 · Cited by 242 · see citing works
Alce, T. M., & Popik, W. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.c400235200 · Cited by 239 · see citing works
氏家, 和., 石丸, 健., Barr, R., Zhang, Y., Khan, M. A., Strebel, K., & Pathak, V. K. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400830101 · Cited by 238 · see citing works
A Single Amino Acid Determinant Governs the Species-specific Sensitivity of APOBEC3G to Vif Action
Mangeat, B., Turelli, P., Liao, S., & Trono, D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.c400060200 · Cited by 237 · see citing works
Self-citationHuman APOBEC3B is a potent inhibitor of HIV-1 infectivity and is resistant to HIV-1 Vif
Doehle, B., Schäfer, A., & Cullen, B. R. (2005) · Virology · doi:10.1016/j.virol.2005.06.005 · Cited by 227 · see citing works
Luo, K., Wang, T., Liu, B., Tian, C., Xiao, Z., Kappes, J. C., & Yu, X.-F. (2007) · Journal of Virology · doi:10.1128/jvi.02584-06 · Cited by 224 · see citing works
Schäfer, A., Bogerd, H. P., & Cullen, B. R. (2004) · Virology · doi:10.1016/j.virol.2004.08.006 · Cited by 223 · see citing works
Bárbaro, G., Scozzafava, A., Mastrolorenzo, A., & Supuran, C. T. (2005) · Current Pharmaceutical Design · doi:10.2174/1381612053764869 · Cited by 222 · see citing works
Structure of the DNA deaminase domain of the HIV-1 restriction factor APOBEC3G
Chen, K., Harjes, E., Gross, P. J., Fahmy, A., Lu, Y., Shindo, K., Harris, R. S., & Matsuo, H. (2008) · Nature · doi:10.1038/nature06638 · Cited by 218 · see citing works
- Authors
- Mangeat, B., Turelli, P., Caron, G., Friedli, M., Perrin, L., & Trono, D.
- Affiliations
- University of Geneva (CH)
- Corresponding author
- Trono, Didier
- Venue
- Nature
- Published
- 2003-05-28
- Volume
- 424
- Issue
- 6944
- Pages
- 99-103
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1966343819
- Cited by
- 1,486
- References
- 28
- Citations by year
- 2026: 20 · 2025: 29 · 2024: 23 · 2023: 28 · 2022: 25 · 2021: 43 · 2020: 37 · 2019: 53 · 2018: 49 · 2017: 56 · 2016: 58 · 2015: 58 · 2014: 79 · 2013: 87 · 2012: 97
- FWCI
- 36.98
- Type
- journal article
- Language
- en
- Open access
- green
- infoscience.epfl.ch
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion, cc-by-nc-nd)
- Topics
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
- Keywords
- APOBEC3G, HIV-1 Vif, APOBEC1, cytosine deamination, reverse transcription, G-to-A hypermutation, retrovirus restriction, T cells, RNA editing
- MeSH terms
- APOBEC-3G Deaminase, Antiviral Agents, Base Sequence, Cell Line, Cytidine Deaminase, DNA, Viral, Humans, Molecular Sequence Data, Nucleoside Deaminases, Proteins, Repressor Proteins, RNA, Messenger, Transcription, Genetic, Virus Replication, HIV-1, Mutagenesis, Gene Products, vif, Point Mutation, RNA Editing, Viral Load, vif Gene Products, Human Immunodeficiency Virus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review